News
News from us and our partners
News
News
Industrial Biotech
News
Capital
News
Digital Medicine
News
Tags
Topics
0 results
- News
Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei Corporation
- News
NodThera announces appointment of Daniel Swisher as Chief Executive Officer
- News
Noema Pharma announces first patient dosed in Phase 2a Study of NOE-115, a first-in-class investigational therapy for the treatment of vasomotor symptoms and additional symptoms associated with menopause
- News
Qorium bolsters Board with appointment of Elizabeth Bastoni and Martin Brok, renowned experts in the consumer goods and retail sectors
- News
May Health raises $25 million in Series B funding to advance development for Ovarian Rebalancing therapy
- News
GenSight Biologics announces a successful offering for an amount over €9.2 million
- News
Mediar advances first-in-class fibrosis portfolio to the clinic with first cohort dosing in Phase 1 trial of MTX-463 and establishes clinical advisory board
- News
Calliditas announces positive topline results of Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib
- News
Amolyt Pharma granted FDA Fast Track Designation for eneboparatide for the treatment of hypoparathyroidism
- News
Sofinnova’s newest partners discuss their career paths
- News
Sofinnova Partners appoints two new partners, strengthening team of next generation investors
- News
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atopic dermatitis
- News
Sensorion announces a €15 Million financing, extending cash runway until the end of 2025
- News
Johnson & Johnson to acquire Shockwave Medical
- News
Moon Surgical expands to gynecological surgery